{
    "eid": "2-s2.0-85064500141",
    "title": "Population pharmacokinetics and pharmacodynamics of piperacillin in critically ill patients during the early phase of sepsis",
    "cover-date": "2019-06-15",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Critically ill patients",
        "Pharmacodynamics",
        "Piperacillin",
        "Population pharmacokinetics",
        "Sepsis",
        "\u03b2-Lactams"
    ],
    "authors": [
        "Waroonrat Sukarnjanaset",
        "Sutep Jaruratanasirikul",
        "Thitima Wattanavijitkul"
    ],
    "citedby-count": 12,
    "ref-count": 38,
    "ref-list": [
        "Appropriate antibiotic therapy",
        "Piperacillin: human pharmacokinetics after intravenous and intramuscular administration",
        "Comparative pharmacokinetics of piperacillin in normals and in patients with renal failure",
        "Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model",
        "Antimicrobial pharmacodynamics: critical interactions of \u2018bug and drug\u2019",
        "Targeted benefits of prolonged-infusion piperacillin-tazobactam in an in vitro infection model of Pseudomonas aeruginosa",
        "Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock - does the dose matter?",
        "Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance data",
        "Pharmacokinetic/pharmacodynamic analysis of meropenem for the treatment of nosocomial pneumonia in intracerebral hemorrhage patients by monte carlo simulation",
        "The third international consensus definitions for sepsis and septic shock (Sepsis-3)",
        "Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations",
        "Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit",
        "Time to treatment and mortality during mandated emergency care for sepsis",
        "Impaired target site penetration of b-lactams may account for therapeutic failure in patients with septic shock",
        "Piperacillin penetration into tissue of critically ill patients with sepsis-bolus versus continuous administration?",
        "Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock",
        "First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis",
        "Pharmacokinetic analysis of piperacillin administered with tazobactam in critically ill, morbidly obese surgical patients",
        "Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?",
        "Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?",
        "Pharmacokinetics of piperacillin in critically ill australian indigenous patients with severe sepsis",
        "Implications of augmented renal clearance on drug dosing in critically ill patients: a focus on antibiotics",
        "Population pharmacokinetics of piperacillin in sepsis patients: should alternative dosing strategies be considered?",
        "High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin",
        "Evaluation of FOCEI and SAEM estimation methods in population pharmacokinetic analysis using NONMEM\u00aeacross rich, medium, and sparse sampling data",
        "Antimicrobial dosing in obese patients",
        "Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen",
        "Pulse pressure and mean arterial pressure in relation to ischemic stroke among patients with uncontrolled hypertension in rural areas of China",
        "Population pharmacokinetic analysis of piperacillin/tazobactam in korean patients with acute infections",
        "Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with nosocomial infections",
        "Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients",
        "Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection",
        "Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: a structured review",
        "Continuous beta-lactam infusion in critically ill patients: the clinical evidence",
        "Population pharmacokinetics of piperacillin in nonobese, obese, and morbidly obese critically ill patients",
        "Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units",
        "Empirical antibiotic therapy for patients with severe sepsis and septic shock"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chula-longkorn University",
        "Chulalongkorn University",
        "Faculty of Medicine, Prince of Songkla University"
    ]
}